Aptus Capital Advisors, LLC Alpha Tau Medical Ltd. Transaction History
Aptus Capital Advisors, LLC
- $6.27 Billion
- Q3 2024
A detailed history of Aptus Capital Advisors, LLC transactions in Alpha Tau Medical Ltd. stock. As of the latest transaction made, Aptus Capital Advisors, LLC holds 21,945 shares of DRTS stock, worth $67,590. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,945
Previous 21,945
-0.0%
Holding current value
$67,590
Previous $55,000
5.45%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding DRTS
# of Institutions
29Shares Held
1.36MCall Options Held
0Put Options Held
0-
Levin Capital Strategies, L.P. New York, NY307KShares$946,5610.07% of portfolio
-
Hoyle Cohen, LLC269KShares$828,7910.05% of portfolio
-
High Tower Advisors, LLC Chicago, IL231KShares$710,5680.0% of portfolio
-
ETF Managers Group, LLC Summit, NJ66.3KShares$204,2840.01% of portfolio
-
Satovsky Asset Management LLC53.6KShares$165,1060.03% of portfolio
About Alpha Tau Medical Ltd.
- Ticker DRTS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 69,011,296
- Market Cap $213M
- Description
- Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast canc...